[HTML][HTML] Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the …
RP Insinga, EJ Dasbach, EH Elbasha - BMC infectious diseases, 2009 - Springer
Background Natural history models of human papillomavirus (HPV) infection and disease
have been used in a number of policy evaluations of technologies to prevent and screen for …
have been used in a number of policy evaluations of technologies to prevent and screen for …
[HTML][HTML] The vaginal microbiota associates with the regression of untreated cervical intraepithelial neoplasia 2 lesions
A Mitra, DA MacIntyre, G Ntritsos, A Smith… - Nature …, 2020 - nature.com
Emerging evidence suggests associations between the vaginal microbiota (VMB)
composition, human papillomavirus (HPV) infection, and cervical intraepithelial neoplasia …
composition, human papillomavirus (HPV) infection, and cervical intraepithelial neoplasia …
[HTML][HTML] End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24–45 years of age
X Castellsagué, N Muñoz, P Pitisuttithum… - British journal of …, 2011 - nature.com
Background: Previous analyses from a randomised trial in women aged 24–45 years have
shown the quadrivalent human papillomavirus (qHPV) vaccine to be efficacious in the …
shown the quadrivalent human papillomavirus (qHPV) vaccine to be efficacious in the …
Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24–45 years: a randomised …
N Muñoz, R Manalastas, P Pitisuttithum, D Tresukosol… - The Lancet, 2009 - thelancet.com
Background Although the peak incidence of human papillomavirus (HPV) infection occurs in
most populations within 5–10 years of first sexual experience, all women remain at risk for …
most populations within 5–10 years of first sexual experience, all women remain at risk for …
An estimate of the public health impact and cost-effectiveness of universal vaccination with a 9-valent HPV vaccine in Germany
N Largeron, KU Petry, J Jacob, F Bianic… - Expert review of …, 2017 - Taylor & Francis
ABSTRACT Introduction: Since 2007, the German Standing Vaccination Committee
recommends HPV vaccination for girls aged 12–17 with a 2-(Cervarix®) or 4-valent …
recommends HPV vaccination for girls aged 12–17 with a 2-(Cervarix®) or 4-valent …
Incident cervical HPV infections in young women: transition probabilities for CIN and infection clearance
RP Insinga, G Perez, CM Wheeler, LA Koutsky… - … Biomarkers & Prevention, 2011 - AACR
Background: We describe transition probabilities for incident human papillomavirus (HPV)
16/18/31/33/35/45/52/58/59 infections and cervical intraepithelial neoplasia (CIN) 1 lesions …
16/18/31/33/35/45/52/58/59 infections and cervical intraepithelial neoplasia (CIN) 1 lesions …
[HTML][HTML] Treatment of HPV infection-associated low grade cervical intraepithelial neoplasia with 5-aminolevulinic acid-mediated photodynamic therapy
D Li, F Zhang, L Shi, L Lin, Q Cai, Y Xu - Photodiagnosis and photodynamic …, 2020 - Elsevier
Objective To investigate the efficacy of 5-aminoketovalic acid (5-ALA) photodynamic therapy
(PDT) in the treatment of patients with low cervical intraepithelial neoplasia (CINI) combined …
(PDT) in the treatment of patients with low cervical intraepithelial neoplasia (CINI) combined …
Presence of HPV DNA in extracellular vesicles from HeLa cells and cervical samples
M Mata-Rocha, RM Rodríguez-Hernández… - … Y Microbiologia Clinica, 2020 - Elsevier
Introduction The main cause of cervical cancer is an infection of keratinocytes in the basal
layer of the stratified epithelium of the cervix by human papillomavirus (HPV). Other than in …
layer of the stratified epithelium of the cervix by human papillomavirus (HPV). Other than in …
Cost‐effectiveness of human papillomavirus vaccination for adolescent girls in Punjab state: implications for India's universal immunization program
S Prinja, P Bahuguna, DS Faujdar, G Jyani… - Cancer, 2017 - Wiley Online Library
BACKGROUND Introduction of human papillomavirus (HPV) vaccination for adolescent girls
is being considered in the Punjab state of India. However, evidence regarding cost …
is being considered in the Punjab state of India. However, evidence regarding cost …
Comparative cost-effectiveness of the quadrivalent and bivalent human papillomavirus vaccines: a transmission-dynamic modeling study
Background The quadrivalent and bivalent human papillomavirus (HPV) vaccines are now
licensed in several countries. We compared the cost-effectiveness of the HPV vaccines to …
licensed in several countries. We compared the cost-effectiveness of the HPV vaccines to …